Effect of Empiric Low-Dose Amphotericin B on the Development of Disseminated Candidiasis in Surgical Intensive Care Unit.
Abstract
Over three and one half years, 28 patients entered the protocol. No subject had any unexpected adverse reaction. No conclusions may be reached regarding the potential benefit of early use of low dose Amphotericin B to prevent dissemination of fungal disease. The progress of this study was impacted by a decrease in the number of patients infected with candida at WRAMC.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 10, 1995
- Accession Number
- ADA293748
Entities
People
- Douglas N. Whatmore
Organizations
- Walter Reed Army Medical Center